Cannabis stocks rally anew as $7 billion GW Pharma deal spurs interest in weed and its medical benefits
February 03, 2021 at 13:22 PM EST
Cannabis stocks rallied anew on Wednesday, spurred on by news of a $7 billion deal for the first company to win U.S. regulatory approval for a cannabis-based drug, a move that's expected to boost investor interest in the plant and its medical benefits.